Arcadia Biosciences competitors

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

John prides himself as a builder of growing international businesses and organizations, successfully deploying both organic and M&A strategies in doing so. As President & CEO since June 2012, John has lead the turnaround and growth of Codexis Inc, the Nasdaq-listed protein engineering company based in Silicon Valley, California. Prior to Codexis, John worked in various business leadership roles for more than 22 years at Albemarle Corporation, a maker of highly engineered specialty chemicals. Spanning three successive multi-year chapters there, John lead the growth of the company’s largest, billion dollar plus global catalyst business, turned around a struggling half billion dollar fine chemicals business, and expanded and globalized Albemarle’s flame retardants business. A native of New York city, John and his family have lived widely across the USA, and also enjoyed an exciting three year assignment in Tokyo, Japan in the late 1990’s. John received a bachelor’s degree in chemical engineering from the Polytechnic Institute of New York University (now NYU) and an MBA from the Massachusetts Institute of Technology. Outside of work, John proudly boasts about his 30 year marriage, two fabulous children, and four delightful grandchildren. John also has passionately applied himself to help solve the plight of the millions of patients suffering from myalgic encephalomyelitis / chronic fatigue syndrome, and is the Board Chair for the leading patient lead organization for the cause in the US, the Solve ME/CFS Initiative (www.solvecfs.org).

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

John Powell Mackey (born August 15, 1953) is an American businessman and writer. He is the CEO of Whole Foods Market, which he co-founded in 1980. Named Ernst & Young entrepreneur of the year in 2003, he is one of the most influential advocates in the movement for organic food.

Rick Winningham has served as a member of our Board of Directors since May 2010. Since 2001, he has served as the Chief Executive Officer and a member of the Board of Directors of Theravance, Inc., a biopharmaceutical company, and in April 2010, he was appointed Chairman of the Board of Directors. From 1997 to 2001, he served as President of Bristol-Myers Squibb Oncology/Immunology/Oncology Therapeutics Network and, from 2000 to 2001, as President of Global Marketing. He is a member of the board of directors of the California Healthcare Institute (CHI) and is also a member of the External Advisory Board for the College of Business and Administration and Business Hall of Fame at Southern Illinois University.Rick Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University.